Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | WT1 sensitized T cells |
| Synonyms | |
| Therapy Description |
WT1 sensitized T cells are T cells that have been sensitized to Wilms' Tumor Protein 1 (WT1), which have the potential to bind to WT1 expressing cells and induce cellular lysis (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| WT1 sensitized T cells | WT1 sensitized T cells are T cells that have been sensitized to Wilms' Tumor Protein 1 (WT1), which have the potential to bind to WT1 expressing cells and induce cellular lysis (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01640301 | Phase Ib/II | Aldesleukin WT1 sensitized T cells | Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant | Terminated | USA | 0 |